Ingeborg Simonsson
99 IP cases indexed. Covers patent matters.
Cases Presided Over
99 cases indexed | Page 2 of 4
Boehringer Ingelheim International GmbH v.Zentiva Portugal, LDA.
In a significant decision regarding generic drug competition, the UPC Court of Appeal granted provisional measures in favor of Boehringer Ingelheim against Zentiva. The court held that the completion of national health technology assessments and reimbursement procedures for generics can constitute an imminent infringement threat, even before market launch. This ruling reinforces the proactive nature of the UPC's jurisdiction across all member states, providing a strong deterrent against premature generic entry.
Swarco Futurit Verkehrssignalsysteme GmbH v.Strabag Infrastructure & Safety Solutions GmbH
This UPC appellate decision addressed a request for confidentiality regarding technical data and measurement reports in an infringement case involving traffic signaling systems. The court confirmed that certain non-obvious product properties qualify as trade secrets under Article 58 EPC, provided they are kept confidential. While the court granted protection to specific documents submitted by Strabag, it rejected broader requests from both Swarco (the claimant) and Chainzone (the assisting party), setting clear boundaries on information disclosure in UPC proceedings.
Tiroler Rohre GmbH v.SSAB Swedish Steel GmbH, SSAB Europe Oy
This UPC appellate decision addressed an appeal concerning the allocation of legal costs following the withdrawal of a provisional measures application. The court confirmed that even when a case is closed by withdrawal under R. 265 VerfO, the general rules for separate cost determination (R. 150 ff. VerfO) apply. The appellate panel found no grounds to overturn the initial costs decision, which had already conducted a thorough and reasonable assessment of the incurred expenses.
Ballinno B.V. v.Kinexon GmbH, Kinexon Sports & Media GmbH, Union des Associations Européennes de Football (UEFA)
This UPC Court of Appeal decision addresses a case concerning security for costs and the disposal of an action that has become devoid of purpose. The claimant, Ballinno B.V., initially sought provisional measures related to patent EP 1 944 067 but subsequently withdrew these requests on appeal. Consequently, the court disposed of the action while rejecting Ballinno's request to set aside the security for costs. This ruling reinforces procedural principles regarding case abandonment and cost allocation in UPC litigation.
Alexion Pharmaceuticals, Inc. v.Samsung Bioepis NL B.V.
This UPC Court of Appeal decision addresses a request for a rehearing based on alleged fundamental procedural defects in a prior ruling. Alexion Pharmaceuticals sought to reopen proceedings concerning its patent EP 3 167 888, arguing that the court applied new standards without proper notice. The Court ultimately rejected the application, clarifying that a rehearing is an extraordinary remedy reserved only for truly fundamental flaws, not mere errors of legal reasoning or disagreement with the outcome.
Alexion Pharmaceuticals, Inc. v.Amgen Technology (Ireland) Unlimited Company; Amgen N.V.; Amgen GmbH; Amgen AB; Amgen S.A.S.; Amgen s.r.l.; Amgen Biofarmacêutica Lda.; Amgen Zdravila D.O.O.
This UPC Court of Appeal decision addresses a request for a rehearing filed by Alexion Pharmaceuticals against Amgen, challenging an earlier ruling. The court clarified the extremely narrow scope of Art. 81(1) UPCA, emphasizing that a rehearing is not a regular appeal mechanism. The court ruled that procedural errors must be 'fundamental'—so severe they are intolerable to the legal system and would have prevented the decision from being reached—and rejected Alexion’s application.
Yellow Sphere Innovations GmbH v.Knaus Tabbert AG
This UPC decision addresses a procedural challenge ('Gegenvorstellung') brought by Knaus Tabbert against the Appeal Court's rejection of its request for interim relief. The court ruled that such a counter-submission is inadmissible if it only disputes the reasoning of the rejecting order, not the merits itself. This ruling reinforces strict procedural boundaries within the UPC system regarding appeals and motions for provisional measures.
Hanshow Technology Co., Ltd. v.VusionGroup SA
This UPC Court of Appeal decision addresses a procedural dispute concerning the timely filing and recovery of costs in patent litigation. The appellant (Hanshow) sought an extension for its cost claim related to the appeal proceedings against VusionGroup. The court strictly upheld the procedural requirements, ruling that extensions are not available for missed deadlines under R. 151 VerfO. This decision reinforces the importance of strict adherence to UPC timelines and clarifies the scope of costs recovery in summary cost proceedings.
Tandem Diabetes Care Europe B.V. v.Roche Diabetes Care GmbH
Tandem Diabetes Care appealed a decision from the Central Division Paris regarding the revocation of EP 2 196 231, which covered an ambulatory drug infusion system. Before the Court of Appeal could rule on the appeal, both parties reached a settlement agreement. The UPC Court of Appeal subsequently confirmed this settlement, formally terminating all proceedings related to the patent.
Hybridgenerator ApS v.HGSystem ApS, HGSystem Holding ApS, Infotech Concept ApS, Infotech Holding ApS
This UPC Court of Appeal decision clarifies the mandatory procedural requirements for imposing periodic penalty payments under R. 354.4 RoP. The court ruled that such an intrusive measure must be decided by a panel, not a single judge. Consequently, the appeal was successful, leading to the setting aside of the initial order and referral back to the Court of First Instance for proper adjudication.
Koninklijke Philips N.V. v.Belkin Limited, Belkin International, Inc., Belkin GmbH
This UPC appellate decision addressed a penalty payment case stemming from an initial disclosure order in an infringement action involving Philips and Belkin regarding patent EP 2 867 997. The court confirmed the validity of imposing a daily penalty for non-compliance, even if compliance is eventually achieved late. Crucially, it reinforced the obligation to disclose manufacturer prices under Art. 67 EPC, providing clear guidance on procedural enforcement and disclosure requirements in UPC litigation.
Chainzone Technology (Foshan) Co., Ltd. v.SWARCO Futurit Verkehrssignalsysteme GmbH
This UPC Board of Appeal decision concerns an application by Chainzone Technology to suspend the effect of a judgment against it, which had found it liable for patent infringement. The appeal was filed following a local court ruling that largely favored Swarco, the patent holder. The Board ultimately rejected Chainzone's request for suspension, citing insufficient substantiation in its legal arguments regarding the interpretation of the patent claim.
NJOY Netherlands B.V. v.Juul Labs International Inc.
This UPC Court of Appeal decision concerns a procedural matter where NJOY Netherlands B.V. sought to withdraw an appeal against Juul Labs International Inc. The underlying action was a revocation suit brought before the CFI, which had previously dismissed it. Given that both parties consented to the withdrawal, the CoA permitted the closure of the proceedings. This case highlights the importance of party consent in procedural matters under the UPC Rules of Procedure.
Yellow Sphere Innovations GmbH v.Knaus Tabbert AG
This UPC Board of Appeal decision addresses an application for interim relief concerning patent infringement. The court ruled that the requirement for a security deposit to ensure enforcement is not automatic and must be assessed on a case-by-case basis by the lower court. The ruling emphasizes that parties should raise all relevant facts, including financial vulnerabilities, during the initial proceedings rather than relying solely on them in an appeal.
Ballinno B.V. v.Union des Associations Européennes de Football (UEFA), Kinexon Sports & Media GmbH, Kinexon GmbH
This UPC Court of Appeal decision addresses the critical procedural issue of an action becoming 'devoid of purpose' when a claimant withdraws its urgent requests for provisional measures. The case involved Ballinno B.V., patent holder, and UEFA/Kinexon companies regarding offside detection technology. The court clarified that claimants who take the inherent risk of basing their strategy on temporary events must accept the consequence of bearing costs if the interest expires before a final ruling.
Hybridgenerator ApS v.HGSystem Holding ApS, HGSystem ApS, Infotech Concept ApS, Infotech Holding ApS
This UPC Court of Appeal decision addresses procedural matters in an appeal concerning penalty payments related to EP 4 238 202. The parties, despite being Danish companies represented by Danish counsel, mutually agreed to change the language of the limited-scope proceedings from Danish to English. The court granted this request, finding it convenient and fair for a quicker adjudication process. This ruling reinforces the flexibility of the UPC in adapting procedural rules based on party consent.
Meril Life Sciences Pvt. Ltd v.SWAT Medical AB and Respondent 1 (Helsingborg)
This UPC Court of Appeal decision addressed procedural issues concerning public access to court documents and representation requirements. The court ruled that an individual holding a high-level management position cannot simultaneously act as their own representative in UPC proceedings, emphasizing due process. Additionally, the ruling clarified that cost compensation is generally not available for requests made under R. 262.1(b) RoP regarding public access to the register.
Meril Italy S.r.l. v.SWAT Medical AB
This UPC Court of Appeal decision addresses procedural matters, specifically the requirements for representation and public access to court documents. The court ruled that an individual holding a high-level management position cannot represent their company in UPC proceedings, emphasizing due process considerations. Additionally, the ruling clarifies that applications seeking access to the register generally do not qualify for cost compensation under the UPC rules. This decision is significant for practitioners as it reinforces strict procedural requirements regarding representation and sets clear boundaries on recoverable costs related to public disclosure requests.
Meril GmbH v.SWAT Medical AB and Respondent 1 (Helsingborg)
This UPC Court of Appeal decision addresses critical procedural issues, specifically concerning public access to the register and the rules governing representation in court. The court established that an individual holding a high-level management position within a party cannot simultaneously act as their authorized representative before the UPC. Additionally, it firmly ruled against awarding compensation for costs related to requests for public access to pleadings, setting clear boundaries on procedural expenses.
NJOY Netherlands B.V. v.Juul Labs International Inc.
In a revocation action concerning EP 3 504 990, the UPC Court of Appeal granted a stay of proceedings at the request of Juul Labs. This decision was based on the accelerated timeline of parallel opposition appeal proceedings before the EPO Boards of Appeal. The ruling highlights the practical mechanism for coordinating litigation between the UPC and national/EPO bodies when decisions are expected rapidly.
NJOY Netherlands B.V. v.Juul Labs International, Inc.
In this UPC Court of Appeal decision, the court granted a stay of revocation proceedings following an appeal by Juul Labs against a prior finding. The request was based on parallel opposition proceedings before the EPO Boards of Appeal which had been accelerated. Given that the EPO proceedings were expected to conclude rapidly relative to the scheduled UPC hearing, the court ruled in favor of granting the stay, allowing both parties to await the final outcome at the EPO.
NJOY Netherlands B.V. v.Juul Labs International, Inc.
In this appeal action for revocation, the UPC Court of Appeal granted a stay of proceedings upon request by Juul Labs International, Inc., pending the outcome of parallel opposition proceedings at the EPO Boards of Appeal. The court determined that since the EPO proceedings were accelerated and expected to conclude rapidly relative to the UPC's hearing schedule, staying the appeal was appropriate under R. 295(a) RoP. This decision highlights the practical mechanism for managing concurrent litigation between the Unified Patent Court and the European Patent Office.
Barco N.V. v.Yealink (Europe) Network Technology B.V., Yealink (Xiamen) Network Technology Co. Ltd.
This UPC Court of Appeal decision addressed an application for suspensive effect concerning a cost order issued by the CFI in provisional measures proceedings. Barco N.V., the appellant, sought to suspend the enforcement of a €112,000 cost award against it. The Court ultimately rejected this request, upholding the principle that appeals generally lack suspensive effect unless exceptional circumstances are met. This case reinforces the strict application of procedural rules regarding the suspension of judicial decisions within the UPC framework.
Stäubli Tec-Systems GmbH v.ehemalige Patentinhaber
This UPC appellate decision addresses a complex issue regarding cost allocation in patent litigation where one party initiates an invalidity action and the other subsequently waives their rights to the patent. The court ruled that equitable considerations can override strict procedural requirements concerning the timing of a waiver and revocation request under Art. 105a EPC. This provides significant relief for patentees who may have delayed formalizing their withdrawal due to complex legal circumstances.
Syngenta Limited v.Sumi Agro Europe Limited
In a significant ruling on provisional measures, the UPC Court of Appeal affirmed the validity and infringement likelihood of EP 2 152 073 concerning herbicide compositions. The court confirmed that the balance of interests favored granting an injunction against Sumi Agro. Furthermore, it clarified procedural aspects, specifically rejecting the requirement for Syngenta to provide security for enforcement, which is a key relief for patent holders seeking immediate protection.
Hanshow Technology Co, Ltd v.VusionGroup SA
This UPC appellate decision addressed procedural disputes regarding costs and the validity of an appeal against a cost determination. VusionGroup argued that Hanshow failed to meet formal requirements for filing the appeal (lack of separate grounds/statement) and defaulted on court fees. The Court ruled in favor of Hanshow, confirming that the initial application for admission contained sufficient detail, thus satisfying procedural requirements for appeals concerning costs. This decision clarifies the flexible nature of procedural rules when challenging cost orders within the UPC.
Meril Italy S.r.l. v.Respondent 1 / SWAT Medical AB
This UPC Court of Appeal decision addressed a critical procedural issue concerning representation before the court. The Court ruled that self-representation is invalid for lawyers and European Patent Attorneys when they are parties to the case, reinforcing strict due process requirements. Additionally, it clarified limitations on corporate representatives acting for legal entities if they lack independence. Consequently, the Court did not dismiss the access request but instead granted a 14-day grace period for the respondents to appoint proper authorized counsel.
Meril Life Sciences Pvt Ltd v.SWAT Medical AB
This UPC Court of Appeal decision addresses critical procedural issues regarding representation before the court. The ruling firmly establishes that self-representation is invalid for lawyers and European Patent Attorneys who are parties to the proceedings. Additionally, it reinforces the principle that corporate representatives holding high-level management roles cannot represent their companies due to independence requirements. The court provided a temporary grace period of 14 days for the involved parties to rectify these procedural defects by appointing proper legal counsel.
Meril Life Sciences Pvt Ltd. v.Meril GmbH
This UPC Court of Appeal decision addresses critical procedural issues regarding representation in the Unified Patent Court, specifically concerning public access requests and party standing. The court ruled that self-representation is invalid for both lawyers/patent attorneys acting as parties and corporate officers holding high-level management roles. This ruling reinforces the strict requirements for legal independence under the UPC Agreement. The decision did not resolve the underlying merits of the case but instead issued an exceptional order, granting the involved parties a short window to appoint proper representatives and remedy procedural defects.
DexCom, Inc. v.Abbott Laboratories and associated companies (including Abbott Diabetes Care Inc., Newyu, Inc.)
In a procedural ruling, the UPC Court of Appeal granted the withdrawal of an infringement action and a counterclaim for revocation involving DexCom, Inc. and Abbott Laboratories/associated companies regarding patent EP 3 831 282. The court emphasized that such withdrawals are permissible during appeal proceedings if no final decision is binding. This case highlights the procedural flexibility within the UPC framework when parties mutually agree to terminate litigation.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.